Chemoinformaics analysis of 4-hydroxycoumarin
| Molecular Weight | 162.144 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 12 |
| Exact Molecular Weight | 162.032 | nRing | 2 |
| Solubility: LogS | -2.18 | nHRing | 1 |
| Solubility: LogP | 1.41 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 21.4368 |
| nHD | 1 | BPOL | 8.62324 |
| QED | 0.597 |
| Synth | 1.903 |
| Natural Product Likeliness | 0.556 |
| NR-PPAR-gamma | 0.198 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.961 |
| HIA | 0.007 |
| CACO-2 | -4.723 |
| MDCK | 0.0000176 |
| BBB | 0.123 |
| PPB | 0.87708 |
| VDSS | 0.525 |
| FU | 0.164783 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.908 |
| CYP2c19-inh | 0.212 |
| CYP2c19-sub | 0.072 |
| CYP2c9-inh | 0.073 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.197 |
| CYP2d6-sub | 0.726 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.204 |
| CL | 12.507 |
| T12 | 0.83 |
| hERG | 0.089 |
| Ames | 0.116 |
| ROA | 0.404 |
| SkinSen | 0.534 |
| Carcinogencity | 0.786 |
| EI | 0.991 |
| Respiratory | 0.433 |
| NR-Aromatase | 0.055 |
| Antiviral | No |
| Prediction | 0.74857 |